Evolus Inc (EVL.BE)
| Previous close | 8.25 |
| Open | 8.25 |
| Bid | 8.05 x 0 |
| Ask | 8.50 x 0 |
| Day's range | 8.20 - 8.40 |
| 52-week range | 6.15 - 10.50 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWPORT BEACH, Calif., September 29, 2023--Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Business Wire
Evolus to Participate in September Conferences
NEWPORT BEACH, Calif., August 29, 2023--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that members of its management team will be participating in two investment conferences in September.
- Business Wire
Evolus Announces Inducement Grants for New Chief Marketing Officer
NEWPORT BEACH, Calif., August 23, 2023--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the Compensation Committee of the Board of Directors approved the grant of stock options to purchase an aggregate of 83,555 shares of Evolus common stock and 63,358 restricted stock units (RSUs) to Tomoko Yamagishi-Dressler, the company’s new Chief Marketing Officer. The stock options and RSUs were granted as of
